Treace Medical Concepts (TMCI) Key Ratios
$4.54
As on 08-Sep-2026 11:33EDT
Market cap
$313 Mln
Revenue (TTM)
$205 Mln
P/E Ratio
--
P/B Ratio
4.7
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -3.86 | -4.24 | -3.95 | 7.13 | 21.44 |
| EBIT | 12.69 | 10.98 | -22.25 | -17.74 | -266.60 |
| Net Profit | 11.63 | 8.77 | -21.01 | -16.03 | -242.27 |
| EPS | 12.25 | 11.63 | -17.90 | -10.07 | -230.22 |
| Book Value | -- | -- | -24.48 | 7.87 | 145.36 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -24.35 | -23.52 | -26.15 | -25.24 | -24.12 |
| Net Margin
| -- | -27.36 | -28.99 | -- | -- |
| Return on equity
| -51.10 | -50.57 | -76.76 | -58.94 | -44.45 |
| Return on Capital
| -33.15 | -32.03 | -- | -41.57 | -28.53 |
| Return on Assets
| -25.61 | -25.58 | -25.28 | -28.95 | -23.77 |
| Debt to Equity (x)
| -- | -- | 0.83 | 0.16 | 0.62 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
--
|
-41.57
|
-28.53
|
-29.36
|
-34.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-76.76
Lower than Peers by 81.74
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
-76.76
|
-58.94
|
-44.45
|
-49.91
|
-55.75
|
|
Peer Median
|
4.98
|
--
|
--
|
--
|
--
|
ROA
-25.28
Lower than Peers by 27.74
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
-25.28
|
-28.95
|
-23.77
|
-24.10
|
-28.56
|
|
Peer Median
|
2.46
|
--
|
--
|
--
|
--
|
EBIT Margin
-26.15
Lower than Peers by 34.68
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
-26.15
|
-25.24
|
-24.12
|
-23.71
|
-27.09
|
|
Peer Median
|
8.53
|
--
|
--
|
--
|
--
|
Net Margin
-28.99
Lower than Peers by 33.73
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
-28.99
|
-27.74
|
-26.63
|
-26.47
|
-31.99
|
|
Peer Median
|
4.75
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-3.95
Lower than Peers by 12.73
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
-3.95
|
0.02
|
0.12
|
0.32
|
0.50
|
|
Peer Median
|
8.78
|
--
|
--
|
--
|
--
|
EBIT Growth
-22.25
Lower than Peers by 33.29
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
-22.25
|
-6.33
|
-13.81
|
-15.47
|
-132.94
|
|
Peer Median
|
11.03
|
--
|
--
|
--
|
--
|
Net Profit Growth
-21.01
Lower than Peers by 34.76
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
-21.01
|
-5.85
|
-12.55
|
-15.68
|
-108.33
|
|
Peer Median
|
13.75
|
--
|
--
|
--
|
--
|
EPS Growth
-17.90
Lower than Peers by 39.34
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
-17.90
|
-0.03
|
-0.11
|
-0.04
|
-1.01
|
|
Peer Median
|
21.44
|
--
|
--
|
--
|
--
|
Book Value Growth
-32.79
Lower than Peers by 39.61
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
-32.79
|
--
|
--
|
--
|
--
|
|
Peer Median
|
6.82
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.83
Higher than Peers by 0.43
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
0.83
|
0.16
|
0.62
|
0.51
|
1.13
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.05
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
0.05
|
--
|
0.00
|
0.01
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.90
Higher than Peers by 0.20
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
2.90
|
4.31
|
4.62
|
4.40
|
4.41
|
|
Peer Median
|
2.70
|
--
|
--
|
--
|
--
|
Quick Ratio
1.95
Lower than Peers by 0.08
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
1.95
|
3.13
|
3.50
|
3.76
|
3.77
|
|
Peer Median
|
2.03
|
--
|
--
|
--
|
--
|
Interest Coverage
-9.23
Lower than Peers by 14.25
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
-9.23
|
-10.09
|
-9.61
|
-8.59
|
-8.74
|
|
Peer Median
|
5.02
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
14.14
Lower than Peers by 2.25
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
14.14
|
19.82
|
19.49
|
20.34
|
20.58
|
|
Peer Median
|
16.39
|
--
|
--
|
--
|
--
|
Asset Turnover
0.87
Higher than Peers by 0.37
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
0.87
|
1.04
|
0.89
|
0.91
|
0.95
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
--
|
71.23
|
68.80
|
65.64
|
61.50
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
--
|
320.21
|
304.43
|
252.15
|
198.34
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
--
|
73.36
|
99.36
|
106.43
|
84.43
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
--
|
318.08
|
273.86
|
211.37
|
175.41
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
--
|
-2.65
|
-8.32
|
-15.88
|
-29.83
|
|
Peer Median
|
46.09
|
--
|
--
|
--
|
--
|
Price / Book Value
4.69
Higher than Peers by 0.91
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
4.69
|
1.79
|
4.11
|
5.70
|
21.10
|
|
Peer Median
|
3.78
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-40.95
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
-40.95
|
-2.83
|
-10.88
|
-18.81
|
-34.85
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
313
Lower than Peers by 222
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Treace Medical Concepts (TMCI)
|
313
|
--
|
--
|
--
|
--
|
|
Peer Median
|
535
|
--
|
--
|
--
|
--
|